Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Trovagene prices $4.5M follow-on

December 15, 2017 9:11 PM UTC

On Dec. 15, cancer company Trovagene Inc. (NASDAQ:TROV) raised $4.5 million through the sale of 15 million units at $0.30 in a follow-on underwritten by H.C. Wainwright. Each unit comprises a share an...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Cardiff Oncology Inc.